Market overview
The global marine toxin market is worth USD 149 mn in 2026 and is forecast to reach USD 267 mn by 2036, growing at a 6.0% CAGR. United States is the largest country market and Paralytic shellfish toxins is the largest by toxin type segment.
| Scope | Test kits, certified reference standards and toxin materials for detecting marine biotoxins such as saxitoxin, domoic acid, okadaic acid and brevetoxin in shellfish, seafood and water. |
|---|---|
| Industry | Healthcare |
| Value 2025 | USD 140 mn |
| Value 2026 | USD 149 mn |
| Value 2036 | USD 267 mn |
| CAGR 2026-2036 | 6.0% |
| Volume 2026 | 734 thousand kits |
| Volume 2036 | 1,133 thousand kits |
| Average price 2026 | USD 203 per kit |
| Report price | Starts from USD 1,999 |
| Published | November 2026 |
Request a free sample of this report
Marine Toxin market size and forecast, 2026-2036
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Year | Market value |
|---|---|
| 2026 | USD 149 mn |
| 2027 | USD 158 mn |
| 2028 | USD 168 mn |
| 2029 | USD 178 mn |
| 2030 | USD 188 mn |
| 2031 | USD 200 mn |
| 2032 | USD 212 mn |
| 2033 | USD 224 mn |
| 2034 | USD 238 mn |
| 2035 | USD 252 mn |
| 2036 | USD 267 mn |
Marine Toxin market segmentation
By toxin type
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Paralytic shellfish toxins | 30.0% | 28.4% | USD 45 mn | 5.4% |
| Diarrhetic shellfish toxins | 27.0% | 26.8% | USD 40 mn | 5.9% |
| Amnesic shellfish toxins | 18.0% | 17.8% | USD 27 mn | 5.9% |
| Ciguatera and brevetoxins | 10.0% | 11.4% | USD 15 mn | 7.4% |
| Other toxins | 15.0% | 15.6% | USD 22 mn | 6.4% |
By product
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Rapid test kits | 46.0% | 49.7% | USD 69 mn | 6.8% |
| ELISA kits | 24.0% | 22.5% | USD 36 mn | 5.3% |
| Reference standards | 22.0% | 20.6% | USD 33 mn | 5.3% |
| Other materials | 8.0% | 7.2% | USD 12 mn | 4.8% |
By species source
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Shellfish and mollusc toxins | 32.0% | 30.0% | USD 48 mn | 5.3% |
| Pufferfish and fish toxins | 22.0% | 21.0% | USD 33 mn | 5.5% |
| Cone snail and cnidarian toxins | 20.0% | 24.0% | USD 30 mn | 8.0% |
| Microalgae toxins | 26.0% | 25.0% | USD 39 mn | 5.6% |
By end use
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Neuroscience research | 28.0% | 30.0% | USD 42 mn | 6.7% |
| Food safety testing | 26.0% | 25.0% | USD 39 mn | 5.6% |
| Pharmaceutical development | 24.0% | 27.0% | USD 36 mn | 7.3% |
| Diagnostics and reference standards | 22.0% | 18.0% | USD 33 mn | 3.9% |
By grade
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Analytical standards | 42.0% | 40.0% | USD 63 mn | 5.5% |
| Research grade | 36.0% | 35.0% | USD 54 mn | 5.7% |
| Pharma grade | 22.0% | 25.0% | USD 33 mn | 7.4% |
Top 25 countries for marine toxin by revenue
Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 79.0% of 2026 revenue and the 25 countries below together hold 93.7%.
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| # | Country | Value 2026 | Share 2026 | Value 2036 | CAGR 2026-36 |
|---|---|---|---|---|---|
| 1 | United States | USD 33 mn | 22.0% | USD 57 mn | 5.7% |
| 2 | China | USD 21 mn | 14.0% | USD 46 mn | 8.1% |
| 3 | Japan | USD 15 mn | 10.0% | USD 25 mn | 5.1% |
| 4 | Spain | USD 10 mn | 7.0% | USD 17 mn | 5.2% |
| 5 | France | USD 8.9 mn | 6.0% | USD 15 mn | 5.1% |
| 6 | United Kingdom | USD 7.5 mn | 5.0% | USD 12 mn | 5.1% |
| 7 | Canada | USD 7.5 mn | 5.0% | USD 13 mn | 5.6% |
| 8 | Chile | USD 6.0 mn | 4.0% | USD 12 mn | 7.3% |
| 9 | Norway | USD 4.5 mn | 3.0% | USD 7.7 mn | 5.6% |
| 10 | South Korea | USD 4.5 mn | 3.0% | USD 8.5 mn | 6.7% |
| 11 | Germany | USD 3.1 mn | 2.1% | USD 5.3 mn | 5.6% |
| 12 | Australia | USD 2.6 mn | 1.8% | USD 4.5 mn | 5.7% |
| 13 | Portugal | USD 2.3 mn | 1.5% | USD 4.0 mn | 5.7% |
| 14 | New Zealand | USD 2.0 mn | 1.4% | USD 3.5 mn | 5.6% |
| 15 | Ireland | USD 1.9 mn | 1.3% | USD 3.3 mn | 5.7% |
| 16 | India | USD 1.8 mn | 1.2% | USD 3.0 mn | 5.6% |
| 17 | Brazil | USD 1.6 mn | 1.0% | USD 2.7 mn | 5.6% |
| 18 | Mexico | USD 1.3 mn | 0.8% | USD 2.2 mn | 5.6% |
| 19 | Italy | USD 1.1 mn | 0.7% | USD 1.8 mn | 5.5% |
| 20 | Netherlands | USD 1.0 mn | 0.7% | USD 1.8 mn | 5.7% |
| 21 | Peru | USD 0.86 mn | 0.6% | USD 1.5 mn | 5.6% |
| 22 | Taiwan | USD 0.73 mn | 0.5% | USD 1.2 mn | 5.6% |
| 23 | Thailand | USD 0.67 mn | 0.5% | USD 1.1 mn | 5.5% |
| 24 | Indonesia | USD 0.57 mn | 0.4% | USD 0.99 mn | 5.7% |
| 25 | Turkey | USD 0.49 mn | 0.3% | USD 0.85 mn | 5.7% |
| Rest of world | USD 9.4 mn | 6.3% | USD 17 mn | 5.8% |
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
Competitive landscape
Group 1: Global leaders
- Neogen
- Eurofins Technologies
- R-Biopharm
- Cayman Chemical
- LGC Standards
- Enzo Life Sciences
Group 2: Regional and specialist players
- CIFGA Laboratorios
- Merck KGaA
- NRC Certified Reference Materials Program
- Cawthron Institute
- Latoxan
- Biosense Laboratories
- FUJIFILM Wako
Group 3: Emerging and niche players
- Gold Standard Diagnostics
- Beacon Analytical Systems
- Zeulab
- Alomone Labs
- Unisensor
Research methodology
Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the marine toxin market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.
The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 6.0% is calculated from the resulting values.
The market is divided by toxin type, by product, by species source, by end use, by grade. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.
Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.
Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.
Frequently asked questions
How big is the marine toxin market?
The global marine toxin market is estimated at USD 140 mn in 2025 and USD 149 mn in 2026.
How fast will the marine toxin market grow?
It is forecast to reach USD 267 mn by 2036, a compound annual growth rate of 6.0% from 2026, an increase of USD 118 mn.
Which country is the largest market for marine toxin?
United States is the largest market by revenue at USD 33 mn in 2026, 22.0% of the global total. The three largest countries together hold 46.0%.
Which country is growing fastest?
Among the ten largest markets, China is growing fastest at 8.1% a year from 2026 to 2036.
Which marine toxin segment is largest?
In the by toxin type split, Paralytic shellfish toxins is the largest segment with 30.0% of 2026 revenue.
Who are the leading marine toxin companies?
Global leaders include Neogen, Eurofins Technologies, R-Biopharm, Cayman Chemical.
Need the full report?
Request a sample to see the structure, tables and country detail.
Request a free sampleRelated markets in Healthcare
- AI-Powered Gait & Mobility AnalyticsUSD 151 mn · 11.0% CAGR
- Fat Modular NutritionUSD 147 mn · 5.0% CAGR
- Cystic Fibrosis Nutrition ProductsUSD 145 mn · 3.5% CAGR
- Theranostic Workflow PlatformsUSD 156 mn · 18.0% CAGR
- Dermatology Cryosurgery UnitsUSD 158 mn · 5.0% CAGR
- Canine Fungal Infection TreatmentUSD 159 mn · 5.5% CAGR
- Immunoadsorption ColumnsUSD 160 mn · 6.5% CAGR
- Protein-Free Nutrition ModuleUSD 160 mn · 6.5% CAGR